QuickCheck: Was there a real, medicinal snake oil?
FOR decades, the term 'snake oil' has come to mean something worthless that has been promised to be a cure-all; it is a term synonymous with fake or fraudulent medicine that does not do as advertised.
Indeed, the term came about in the 19th Century and the first two decades of the 20th century because of products proclaimed to contain 'snake oil' that when tested were found to contain nothing from a snake at all – what more their fats or other oils.
That said, it has also been claimed that the oil of some snakes actually has medicinal properties and that it is this that led to people latching on to create these fake 'snake oil' products.
Is this true?
VERDICT:
TRUE
It might come as a shock to some, but there is a historical basis that led to the creation of the fake snake oils that coined the term as we know it today.
This was outlined in a 2015 article in the official journal of The Royal Pharmaceutical Society in the United Kingdom by Andrew Haines, who linked it to Chinese labourers brought into the United States in the 1840s to work on constructing the Transcontinental Railroad.
'They would almost certainly have brought with them oil from the Chinese water-snake (Laticauda semifasciata, black-banded sea krait), which in traditional Chinese medicine has been used for centuries as an anti-inflammatory agent to treat arthritis, bursitis and other joint pains,' says Haines.
He adds in his article in The Pharmaceutical Journal that these labourers may have helped their fellow workers out by offering snake oil to them as relief after long days of back-breaking work.
However, would this oil have actually had any medical benefit? According to Haines, the answer is yes.
'Modern-day research suggests that Chinese water-snake oil may indeed have health benefits because of its high content of omega-3 fatty acids.
In 1989, an analysis of snake oil bought in San Francisco's Chinatown found that it contained 20 per cent eicosapentaenoic acid, which is more than is found in popular omega-3 food sources such as salmon,' he writes in his January 2025 article.
This was also referenced in a 2007 Scientific America article, in which writer Cynthia Graber cites the 1989 study performed by California-based psychiatrist Richard Kunin.
In her article, Graber writes that Kunin visited San Francisco's Chinatown to buy such snake oil and analyse it. He also acquired two live rattlesnakes and extracted their fat sacks to come up with the article he published in the Western Journal of Medicine in 1989.
'Chinese water-snake oil contains 20% eicosapentaenoic acid (EPA), one of the two types of omega-3 fatty acids most readily used by our bodies.
In comparison, the rattlesnakes had only 8.5% EPA. And salmon, one of the most popular food sources of omega-3s, contains a maximum of 18% EPA, lower than that of snake oil,' she writes.
So with the research, maybe there's something to snake oil after all – as long as it's from the right snake, of course.
References
https://pharmaceutical- journal.com/article/opinion/ the-history-of-snake-oil
https://www. scientificamerican.com/ article/snake-oil-salesmen- knew-something/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malaysian Reserve
3 hours ago
- Malaysian Reserve
Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
SINGAPORE, June 14, 2025 /PRNewswire/ — Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MOU). The landmark agreement paves the way for the establishment of a state-of-the-art next generation sequencing (NGS) laboratory in southern China, advancing localized oncology diagnostics. The collaboration will leverage USKBio's existing infrastructure, and Gene Solutions' advanced next-generation AI & genomics capabilities to jointly establish a next-generation sequencing (NGS) laboratory. The lab will focus on accelerating access to early cancer detection and molecular residual disease (MRD) monitoring using AI-powered circulating tumor DNA (ctDNA) technologies, tailored to address the unique clinical needs of southern China's healthcare landscape. USKBio brings extensive expertise in Polymerase Chain Reaction (PCR)-based In Vitro Diagnostics (IVD) and Good Manufacturing Practice (GMP)-certified production capabilities. Gene Solutions contributes its leadership in NGS-based oncology applications, highlighted by its groundbreaking SPOT-MAS test — Asia's first clinically validated multi-cancer early detection (MCED) assay, validated through a prospective study of 9,024 participants. Additionally, Gene Solutions recently published a real-world MRD study involving 623 patients across six cancer types—lung, colorectal, breast, gastric, liver, and ovarian—demonstrating the clinical utility of ctDNA for monitoring treatment response and assessing recurrence risk. This partnership will focus on localizing and validating these cutting-edge technologies for the Chinese market while fostering joint R&D and production of advanced IVD medical devices. This alliance represents a major step forward in delivering accessible, high-impact, personalized cancer diagnostics to a broader population in China. 'This partnership with USKBio allows us to move quickly in establishing a high-impact oncology hub in southern China,' said Dr. Nguyen Hoai Nghia, CEO and Co-founder at Gene Solutions. 'Together, we aim to bring early, accurate, and scalable cancer screening and diagnostics to more patients, ultimately improving cancer outcomes.' 'Gene Solutions and USKBio are highly complementary in their core technologies, regional markets, and business models.' said Dr. Yu Dehua, CEO at USKbio. 'This strategic collaboration will leverage both parties' strengths, creating strong synergies to deliver greater benefits to cancer patients across the Asia region.' The partnership also includes technology transfer, technical training, and joint commercialization efforts to ensure rapid deployment and widespread adoption of these advanced genomic tools. About Shenzhen USKBio Founded in August 2015, Shenzhen USKBio is a national high-tech biological enterprise established by leading Chinese and American scientists and entrepreneurs. Specializing in in vitro molecular diagnostics, USKBio integrates R&D, production, marketing, and medical testing services, with a robust presence in IVD reagents, diagnostic instruments, and testing services. Leveraging proprietary technologies such as Udx-PCR and Udx-MSP, the company offers innovative solutions for early cancer screening, precision diagnosis, and companion diagnostics. With over 36 authorized patents and collaborations across top hospitals and testing institutions in China, USKBio is a rising leader in the global molecular diagnostics industry, dedicated to advancing precision medicine. About Gene Solutions Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring. With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific. Explore more information at:
The Star
a day ago
- The Star
China's photonic chip debut to power AI, 6G and quantum computing push: expert
As China joins the international drive to mass produce high-performance photonic chips, an industry pioneer said the technical performance of its chips will position the country for major advances in artificial intelligence (AI), 6G and quantum computing. Shanghai Jiao Tong University Chip Hub for Integrated Photonics Xplore (CHIPX) announced on June 5 that it had begun producing 6in (15.2cm) wafers for thin-film lithium niobate (TFLN) photonic chips, which rely on light – or photons – rather than electrical signals for information transmission and processing. While this is China's first pilot production line for photonic chips, Europe and the US are already established in the field. Dutch company SMART Photonics last year upgraded its line to process 4in InP wafers, and California-based PsiQuantum revealed in February that it was adapting a 300mm silicon photonics line. China's pilot production line, built on the new TFLN material, may have come later but it is already showing gains in terms of technical performance by overcoming a global limit for high-speed optical links. TFLN is an emerging high-performance optoelectronic material known for its ultra-fast electro-optic effect, high bandwidth and low power consumption. But its brittle nature has hindered large-scale manufacturing. 'Establishing this stable production line is the result of nearly 15 years of effort,' said Professor Jin Xianmin, director of CHIPX. 'I began working on photonic chips in 2010 and focused on lithium niobate from 2018,' Jin said. 'Before this pilot production line, we spent years refining fabrication techniques, building small-scale prototypes, and solving critical issues. 'For instance, achieving efficient coupling between electrodes and the optical chip required a long and technically demanding process from design to tape-out to testing.' Construction of the pilot production line began in 2022 and took three years to complete. It houses more than 110 state-of-the-art fabrication tools using complementary metal-oxide-semiconductor technology, demonstrating full-chain technological self-reliance that includes photolithography, thin-film deposition, etching, wet processing, dicing, metrology and packaging – all tailored for 6in TFLN wafers. 'To ensure stability and reduce uncertainties in both materials science and fabrication techniques, the production line currently uses top-tier international equipment. 'In the future, we have the ability to gradually adopt domestic or refurbished alternatives, with some Chinese teams already able to provide third-party maintenance for the current machinery,' Jin said. While the production process shares similarities with that of electronic chips, it is optimised for photonic applications. Unlike electronic chips, which prioritise miniaturisation and integration, photonic chips require exceptional surface smoothness. The team has adapted techniques such as annealing, a type of heat treatment, to repair microscopic surface defects and improve optical performance. Testing and process improvements allowed the team to achieve advanced results: the modulation bandwidth exceeded 110 gigahertz, overcoming a global limit for high-speed optical links; insertion loss dropped below 3.5 decibels and waveguide loss below 0.2 decibels/cm, greatly improving signal transmission. Meanwhile, the modulation efficiency showed a clear boost in electro-optical performance. 'These lithium niobate photonic chips can function not only as computing servers themselves but also as critical components for photonic-electronic integration,' Jin said. 'They enable the high-speed connection of various computing resources.' The institute envisions a computing architecture that merges optical transmission and optical computing, offering highly parallel, low-latency, and energy-efficient solutions for AI model training and inference. With their ultra-low loss, high bandwidth and rapid signal transmission, lithium niobate modulators are also well suited for cloud computing, supercomputing centres, and future 5G and 6G infrastructure. 'Beyond computing and connectivity, photonic chips also hold promise for applications such as laser gyroscopes, lidar, and biosensing. The field has seen steady research progress over the years, but what it has lacked was a scalable production path,' Jin said. The current pilot line has an annual capacity of 12,000 6in wafers and is capable of rapid, low-cost production. 'Previously, it could take up to a year to fabricate and test a single quantum photonic chip,' Jin said. 'Now, we are iterating weekly. This speed is critical for advancing quantum photonic technologies.' China's photonics industry is gaining momentum, with companies such as Hangzhou's Xili Photonics recently securing major investments. Last month, CHIPX was named one of the Ministry of Industry and Information Technology's first batch of priority-cultivated pilot platforms. 'Our platform is currently a national pioneer,' Jin said. 'This production line can develop prototypes into small-batch production for scientists, research institutes and companies, while also accelerating the validation of cutting-edge technologies – from zero to one.' CHIPX said it aimed to further stabilise its production process, increase yields, experiment with other materials, and eventually scale to 8in wafer fabrication. – South China Morning Post
The Star
a day ago
- The Star
China's orchard of AI, chip grads now ripe for the pickin' as tech trade sours
When Jack Wang enrolled as an undergraduate in microelectronics at a prestigious Chinese university, the year was 2019, and China was in the early days of its trade war with the United States. Looking back, his decision to focus on the field revolving around the design and manufacture of hi-tech microchips has proved prescient. Today, it complements Beijing's aspirations to make world-leading semiconductors amid Washington's amped-up efforts to curtail China's technological progress. Indeed, the sector has grown by leaps and bounds in the six years since Wang laid out his focus of study, and it now serves as the backbone for artificial intelligence (AI) advancements. 'I realised that this industry was booming, and AI had been kind of popular back then – it just wasn't as capable as it is today,' he said. 2019 was also the year that China's Ministry of Education approved the first batch of AI majors at 35 universities, following an action plan in 2018 that sought to turn Chinese universities into global talent hubs leading the development of next-generation AI by 2030. Today, more than 535 universities in China offer AI-related majors, and nearly half of the world's top AI researchers are from the country, according to recent findings by Morgan Stanley. That massive pool of AI talent, in a nation of 1.4 billion people, is giving China a competitive edge in the field that has become a defining battleground in global technological and geopolitical competition, researchers and industry professionals say. But in many respects, they note, China is still seen as lagging behind the US. They point to less industry-academic collaboration, weaker conversion of research into impactful technologies, and a lower risk tolerance among investors. Having been pursuing postgraduate studies in the same field at the same university, Wang is expected to graduate and join China's growing army of AI workers next year. 'Since I entered university, many universities have started their own microelectronics and integrated circuit programmes and expanded their admissions,' he said, noting how this translates into more graduates each year. According to annual reports by the Chinese Ministry of Education, AI undergraduate programmes in Chinese universities have been on a developmental 'fast track' in recent years. In 2020, AI was the most added undergraduate major. Though growth has since slowed, it still ranks among the top newly approved majors. The biggest AI innovations have occurred in the past five years and likely will continue in the next five, when China's abundance of talent will give it exceptional strength, said Zhang Yaqin, head of the Institute of AI Industry Research under Tsinghua University, a world-leading research and education institution in this field. 'China's greatest advantage [in AI] is its talent pool. Young people majoring in AI are emerging at a rate of about five times that of the US, including those from Tsinghua University,' he said during a sci-tech conference in Beijing last month. Ren Zhengfei, founder of Chinese tech giant Huawei Technologies, also sees the large number of young people as China's top advantage in AI development. 'China has hundreds of millions of adolescents, who are the future of our nation,' he was quoted as saying by the People's Daily on Tuesday when asked about the industry's prospects. The number of AI talent reserves in China exceeded 700,000 as of 2024, a year-on-year increase of 25%, according to a report by AI education service provider Beijing Uniwise Technology last year. In 2022, 28% of top AI researchers were working in China, up from only 11% in 2019, according to data from MacroPolo, a think tank of the Chicago-based Paulson Institute. This has mainly been driven by China's vast application scenarios, particularly those close to practical use, said Gu Ning, deputy president of Beijing-based AI start-up Doodod. 'AI is just part of China's tech rise, where it is already exporting technologies and business models, which we can see in the cases of TikTok and Temu,' he said, adding that it 'is creating a favourable environment for professionals'. Job postings for algorithm engineers and machine-learning roles in China were respectively up by 44% and 18%, year on year, during the first quarter of 2025, according to data from Zhaopin, a major Chinese jobs platform. Tech giant Xiaomi is expanding its 20,000-person research and development team to somewhere between 50,000 and 100,000 in the future, founder and CEO Lei Jun said earlier. China's efforts to cultivate AI talent date back to 2018, when the education ministry rolled out an ambitious action plan to guide higher-education institutions to target the global forefront of science and technology and provide strategic support for the development of China's new generation of AI. The large number of graduates from China in related areas produced over the years has been helping to form AI workforces across the Pacific. In 2022, 38% of top-tier AI researchers working in US institutions were of Chinese origin, based on their undergraduate degrees, surpassing the 37% of American origin, according to MacroPolo. 'It now seems that the competition in the entire AI industry is between Chinese people in China and Chinese people in the US,' said Cao Changdan, co-founder of another AI start-up in Beijing. Many Chinese trained or employed in the US have chosen to return home as China represents more opportunity for career advancement, while there is an 'invisible ceiling' for Chinese working in American companies, she said, referring to a prevailing salary cap for them. President Donald Trump is making the environment more difficult as he tightened visa controls on Chinese students and restricted top universities' ability to admit international students in recent weeks. The US-China trade war and unfriendly policies beyond trade have made more entrepreneurs focus on the domestic market, Cao said. In 2023, her company launched a companion robot that was mainly sold overseas, but has now shifted to products targeting domestic users, such as a new AI tool that gives advice to China's university entrance exam takers in their school applications. Despite China's quick catch-up in cultivating and absorbing AI specialists, the US remains attractive partly thanks to its substantial investment in AI research, which tends to be longer-term and has a greater tolerance for mistakes than things are in China, she said. 'Many investments in China come from state-owned capital, which carries the risk of state asset loss, leading to greater caution. As a result, Chinese companies face greater difficulty in securing funding for technological innovation,' she said. Though China now ranks No 1 globally in AI patents and technology clusters, according to the Morgan Stanley report published last month, a robust ecosystem of leading tech companies in the US is also adding to its attractiveness. 'Despite the similar number of research publications in 2023, one of the major factors maintaining the US' leadership in AI industry-driven research is the active involvement of private-sector firms in AI research, which allows for rapid conversion of high-quality research into impactive technologies and applications,' the report said. In contrast, in China, all of the top 10 institutions in AI research are academic institutions, it said. Gu from Doodod believed that developing a mix of academic organisations and private-sector firms is the long-term path to success for China. 'Only content that is genuinely forged through market competition represents the true direction of innovation,' he said. 'AI applications must be profitable to create a virtuous cycle in the industry.' China also needs to reform the evaluation and management of scientific research if it wants to retain more tech talent, urged Chu Zhaohui, a senior researcher at the state-backed China National Academy of Educational Sciences think tank in Beijing. 'The current evaluation system does not encourage creativity but is bureaucratic and seniority-based, with the most prominent issues being its focus on papers and projects, whereas other countries may prioritise outcomes,' he noted. Wang, the microelectronics students, however, is determined to stay in his motherland after graduation. And while many young job-hunters face a bleak labour market due to China's economic slowdown and surplus of graduates, Wang said he believed it would not be hard for him to secure a job, thanks to his speciality. 'My education was all in China, and other countries except the US do not hire many graduates of the microelectronics major,' he said. 'Also, because of Trump's unfriendly policies on foreign students and immigrants, working overseas is not an option for me.' – South China Morning Post
